Genetically modified animals in pharmacological research: Future trends

European Journal of Pharmacology

Volumn 375, Issue 1-3, 1999, Pages 327-337

  Rudolph, Uwe ^a,b   Möhler, Hanns ^a,b  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Gene knockout; Gene targeting; Inducible gene expression; Mutagenesis; Tetracycline; Transgenic

Indexed keywords

DOXYCYCLINE; RECEPTOR SUBTYPE; TETRACYCLINE;

ANIMAL EXPERIMENT; DRUG TARGETING; FUTUROLOGY; GENE EXPRESSION; GENE TARGETING; KNOCKOUT GENE; KNOCKOUT MOUSE; MOUSE; MUTAGENESIS; MUTANT; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING; TRANSGENIC ANIMAL;

ANIMALS; DISEASE MODELS, ANIMAL; FORECASTING; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MUTATION; ORGANISMS, GENETICALLY MODIFIED; PHARMACOGENETICS; PHARMACOLOGY; PROTEIN ISOFORMS; SIGNAL TRANSDUCTION; TOXICOLOGY;

EID: 0345517953     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00195-8     Document Type: Review

References (75)

1. Alton E.M.F.W., Middleton P.G., Caplen N.J., Smith S.N., Steel D.M., Munkonge F.M., Jeffery P.K., Geddes D.M., Hart S.L., Williamson R., Fasold K.I., Miller A.D., Dickinson P., Stevenson B.J., McLachlan G., Dorin J.R., Porteous D.J. Non-invasive liposone-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice. Nat. Genet. 5:1993;135-142.
2. Anonymous, 1997. Mutant mice and neuroscience: recommendations concerning genetic background. Banbury Conference on genetic background in mice. Neuron 19, 755-759.
3. Anonymous, 1998. Making the most of transgenic mice. Nat. Neurosci. 1, 429.
4. Antoch M.P., Song E.J., Chang A.M., Vitaterna M.H., Zhao Y., Wilsbacher L.D., Sangoram A.M., King D.P., Pinto L.H., Takahashi J.S. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell. 89:1997;655-667.
5. Baron U., Schappinger D., Helbl V., Gossen M., Hillen W., Bujard H. Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc. Natl. Acad. Sci. U.S.A. 96:1999;1013-1018.
6. A receptors rendered diazepam-insensitive by point-mutated α-subunits. FEBS Lett. 431:1998;400-404.
7. Buchholz F., Ringrose L., Angrand P.O., Rossi F., Stewart A.F. Different thermostabilities of FLP and Cre recombinases: implications for applied site-specific recombination. Nucleic Acids Res. 24:1996;4256-4262.
8. Buchholz F., Angrand P.O., Stewart A.F. Improved properties of FLP recombinase evolved by cycling mutagenesis. Nat. Biotechnol. 16:1998;657-662.
9. Bürki K., Ledermann B. Transgenic animals as pharmacological tools. Adv. Drug Res. 26:1995;143-177.
10. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A. Jr., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
11. Dymecki S.M. Flp recombinase promotes site-specific DNA recombination in embryonic stem cells and transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;6191-6196.
12. Dymecki S., Tomasiewicz H. Using Flp-recombinase to characterize expansion of Wnt1-expressing neural progenitors in the mouse. Dev. Biol. 201:1998;57-65.
13. Engle S.J., Womer D.E., Davies P.M., Boivin G., Sahota A., Simmonds H.A., Stambrool P.J., Tischfield J.A. HPRT-APRT-deficient mice are not a model for Lesch-Nyhan syndrome. Hum. Mol. Genet. 5:1996;1607-1610.
14. Finger S., Heavens R.P., Sirinathsinghji D.J.S., Kuehn M.R., Dunnett S.B. Behavioral and neurochemical evaluation of a transgenic mouse model for Lesch-Nyhan syndrome. J. Neurol. Sci. 86:1988;203-213.
15. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Liebergurg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
16. Ganten D., Wagner J., Zeh K., Bader M., Mlchel J.M., Paul M., Zimmermann F., Ruf P., Hilgenfeldt U., Ganten U., Kaling M., Bachmann S., Fukamizu A., Mullins J.J., Murakami K. Species specificity of renin kinetics in transgenic rats harboring the human renin and angiotensinogen genes. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7806-7810.
17. Goddard C.A., Ratcliff R., Anderson J.R., Glenn E., Brown S., Gill D.R., Hyde S.C., MacVinish L.J., Huang L., Higgins C.F., Cuthbert A.W., Evans M.J., Colledge W.H. A second dose of a CFTR cDNA-liposome complex is as effective as the first dose in restoring cAMP-dependent chloride secretion to null CF mice trachea. Gene Ther. 4:1997;1231-1236.
18. Grompe M., al-Dhalimy M., Finegold M., Ou C.N., Burlingame T., Kennaway N.G., Soriano P. Loss of fumarylacetoacetate hydrolase is responsible for the neonatal hepatic dysfunction phenotype of lethal albino mice. Genes Dev. 7:1993;2298-2307.
19. Grompe M., Lindstedt S., al-Dhalimy M., Kennaway N.G., Papaconstantinou J., Torres-Ramos C.A., Ou C.N., Findgold M. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinemia type I. Nat. Genet. 10:1995;453-460.
20. Grubb B.R., Pickles R.J., Ye H., Yankaskas J.R., Vick R.N., Engelhardt J.F., Wilson J.M., Johnson L.G., Boucher R.C. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans. Nature. 371:1994;802-806.
21. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 265:1994;103-106.
22. Hooper M., Hardy K., Handyside A., Hunter S., Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature. 326:1987;292-295.
23. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
24. 2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. Br. J. Pharmacol. 122:1997;1339-1344.
25. Hyde S.C., Gill D.R., Higgins C.F., Trezise A.E., MacVinish L.J., Cuthbert A.W., Ratcliff R., Evans M.J., Colledge W.H. Correction of the ion transport defect in cysttic fibrosis transgenic mice by gene therapy. Nature. 362:1993;250-255.
26. Jinnah H.A., Wojcik B.E., Hunt M., Narang N., Lee K.Y., Goldstein M., Wamsley J.K., Langlais P.J., Friedmann T. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J. Neurosci. 14:1994;1164-1175.
27. King D.P., Zhao Y., Sangoram A.M., Wilsbacher L.D., Tanaka M., Antoch M.P., Steeves T.D., Vitaterna M.H., Kornhauser J.M., Lowrey P.L., Turek F.W., Takahashi J.S. Positional cloning of the mouse circadian clock gene. Cell. 89:1997;641-653.
28. Kistner A., Gossen M., Zimmermann F., Jerecic J., Ullmer C., Lübbert H., Bujard H. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10933-10938.
29. Kitamoto T., Nakamura K., Nakao K., Shibuya S., Shin R.-W., Gondo Y., Katsuki M., Tateishi J. Humanized prion protein knock-in by cre-induced site-specific recombination in the mouse. Biochem. Biophys. Res. Commun. 222:1996;742-747.
30. Kleingoor C., Wieland H.A., Korpi E.R., Seeburg P.H., Kettenmann H. Current potentiation by diazepam but not GABA sensitivity is determined by a single histidine residue. NeuroReport. 4:1993;187-190.
31. Kohler S.W., Provost G.S., Fieck A., Kretz P.L., Bullock W.O., Sorge J.A., Putman D.L., Short J.M. Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7958-7962.
32. Kuehn M.R., Bradley A., Robertson E.J., Evans M. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature. 326:1987;295-298.
33. Kühn R., Löhler J., Rennick D., Rajewsky K., Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:1993;263-274.
34. Kühn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
35. 2a-adrenergic receptor via 'hit and run' gene targeting reveals the role of this subtype in sedative, analgesic, and anesthetic-sparing responses in vivo. Proc. Natl. Acad. Sci. U.S.A. 94:1997;9950-9955.
36. Lakso M., Pichel J.G., Gorman J.R., Sauer B., Okamoto Y., Lee E., Alt F.W., Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5860-5865.
37. 2a receptor. Nature. 388:1997;674-678.
38. Li Y., Erzurumlu R.S., Chen C., Jhaveri S., Tonegawa S. Whisker-related neuronal patterns fail to develop in the trigeminal brainstem nuclei of NMDAR1 knockout mice. Cell. 76:1994;427-437.
39. 2-adrenergic receptor subtypes b and c. Science. 273:1996;803-805.
40. 2a-adrenergic receptor subtype. Science. 273:1996;801-803.
41. Mansuy I.M., Mayford M., Jacob B., Kandel E.R., Bach M.E. Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell. 92:1998;39-49.
42. Mansuy I.M., Winder D.G., Moallem T.M., Osman M., Mayford M., Hawkins R.D., Kandel E.R. Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron. 21:1998;257-265.
43. Meyers E.N., Lewandoski M., Martin G.R. An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination. Nat. Genet. 18:1998;136-141.
44. Mombaerts P., Mizoguchi E., Grusby M.J., Glimcher L.H., Bhan A.K., Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell. 75:1993;275-282.
45. Myhr B.C. Validation studies with Muta Mouse: a transgenic mouse model for detecting mutations in vivo. Environ. Mol. Mutagen. 18:1991;308-315.
46. q-deficient mice. Nature. 389:1997;183-186.
47. Overturf K., al-Dhalimy M., Ou C.N., Finegold M., Tanguay R., Lieber A., Kay M., Grompe M. Adenovirus-mediated gene therapy in a mouse model of hereditary tyrosinemia type I. Hum. Gene Ther. 8:1997;513-521.
48. Overturf K., al-Dhalimy M., Manning K., Ou C.N., Finegold M., Grompe M. Ex vivo hepatic gene therapy of a mouse model of hereditary tyrosinemia Type I. Hum. Gene Ther. 9:1998;295-304.
49. Reichardt H.M., Kaestner K.H., Tuckermann J., Kretz O., Wessely O., Bock R., Gass P., Schmid W., Herrlich P., Angel P., Schütz G. DNA binding of the glucocorticoid receptor is not essential for survival. Cell. 93:1998;531-541.
50. Rohlmann A., Gotthardt M., Willnow T.E., Hammer R.E., Herz J. Sustained somatic gene inactivation by viral transfer of Cre recombinase. Nat. Biotechnol. 14:1996;1562-1565.
51. Rohlmann A., Gotthardt M., Hammer R.E., Herz J. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101:1998;689-695.
52. Rubin E.M., Smith D.J. Optimizing the mouse to sift sequence for function. Trends Genet. 11:1997;423-426.
53. Rudolph U., Möhler H. Transgenic and targeted mutant mice in drug discovery. Curr. Opin. Drug Discovery Dev. 2:1999;134-141.
54. i2-deficient mice. Nat. Genet. 10:1995;143-150.
55. A-receptor subtypes: mice with point-mutated diazepam-insensitive α1-subunits. Soc. Neurosci. Abstr. 24:1998;1990.
56. Sacco M.G., Zecca L., Bagnasco L., Chiesa G., Parolini C., Bromley P., Cato E.M., Roncucci R., Clerici L.A., Vezzoni P. A transgenic mouse model for the detection of cellular stress induced by toxic inorganic compounds. Nat. Biotechnol. 15:1997;1392-1397.
57. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:1993;253-261.
58. 2C-receptors modulate the acoustic startle reflex, prepulse inhibition, and aggression in mice. J. Neurosci. 18:1998;3035-3042.
59. Sauer B. Manipulation of transgenes by site-specific recombination: use of cre recombinase. Methods Enzymol. 225:1993;890-900.
60. Schwenk F., Kühn R., Angrand P.O., Rajewsky K., Stewart A.F. Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res. 26:1998;1427-1432.
61. Stacey A., Schnieke A., McWhir J., Cooper J., Colman A., Melton D.W. Use of double-replacement gene targeting to replace the murine α-lactalbumin gene with its human counterpart in embryonic stem cells and mice. Mol. Cell. Biol. 14:1994;1009-1016.
62. Stacey A., Schnieke A., Kerr M., Scott A., McKee C., Cottingham I., Binas B., Wilde C., Colman A. Lactation is disrupted by α-lactalbumin deficiency and can be restored by human α-lactalbumin gene replacement in mice. Proc. Natl. Acad. Sci. U.S.A. 92:1995;2835-2839.
63. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.H., Mistl C., Rothacher S., Ledermann B., Bürki K., Frey P., Paganetti P.A., Waridel C., Calhoun M.E., Jucker M., Probst A., Staufenbiel M., Sommer B. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology. Proc. Natl. Acad. Sci. 94:1997;13287-13292.
64. Takahashi J.S., Pinto L.H., Vitaterna M.H. Forward and reverse genetic approaches to behavior in the mouse. Science. 264:1994;1724-1733.
65. Tarutani M., Itami S., Okabe M., Ikawa M., Tezuka T., Yoshikawa K., Kinoshita T., Takeda J. Tissue-specific knockout of the mouse Pig-a gene reveals important roles for GPI-anchored proteins in skin development. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7400-7405.
66. Tsien J.Z., Chen D.F., Gerber D., Tom C., Mercer E.H., Anderson D.J., Mayford M., Kandel E.R., Tonegawa S. Subregion- and cell type-restricted gene knockout in mouse brain. Cell. 87:1996;1317-1326.
67. Tsien J.Z., Huerta P.T., Tonegawa S. The essential role of hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell. 87:1996;1327-1338.
68. Vayssiére B.M., Dupont S., Choquart A., Petit F., Garcia T., Marchandeau C., Gronemeyer H., Resche-Rigon M. Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol. Endocrinol. 11:1997;1245-1255.
69. Vitaterna M.H., King D.P., Chang A.M., Kornhauser J.M., Lowrey P.L., McDonald J.D., Dove W.F., Pinto L.H., Turek F.W., Takahashi J.S. Mutagenesis and mapping of a mouse gene, Clock, essential for circadian behavior. Science. 264:1994;719-725.
70. Wang Y., Krushel L.A., Edelman G.M. Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene. Proc. Natl. Acad. Sci. U.S.A. 93:1996;3932-3936.
71. Wei L.-N. Transgenic animals as new approaches in pharmacological studies. Annu. Rev. Pharmacol. Toxicol. 37:1997;119-141.
72. A receptors is essential for benzodiazepine agonist binding. J. Biol. Chem. 267:1992;1426-1429.
73. Zambrowicz B.P., Friedrich G.A., Buxton E.C., Lilleberg S.L., Person C., Sands A.T. Disruption and sequence identification of 2000 genes in mouse embryonic stem cells. Nature. 392:1998;608-611.
74. Zhuang X., Ramboz S., Compan V., Oosting I.M., Mansuy I.M., Kandel E.R. Tissue-specific knockout of the 5-HT1A receptor: autoreceptor versus heteroreceptor knockout. Soc. Neurosci. Abstr. 24:1998;1990.
75. Zou Y.-R., Gu H., Rajewsky K. Generation of a mouse strain that produces immunoglobulin κ chains with human constant regions. Science. 262:1993;1271-1274.